← Back to headlines
Market Analysts View Stevanato Group Rally as Overreaction to Oral GLP-1 Launches
Investment firm Riverwater characterizes the recent surge in Stevanato Group stock as a market overreaction following the commercial rollout of oral GLP-1 diabetes medications.
1 Sept, 12:50 — 1 Sept, 12:50
Sources
Showing 1 of 1 sources
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
1h ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago